2,259,943 Shares CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2011 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 8th, 2011 Company Industry JurisdictionCatalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of 2,259,943 authorized but unissued shares (the “Shares”) of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company.